US 8048418
Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 8048418 (Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K2039/507